Abilify and Stelara drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Stelara (ustekinumab). Common drug interactions include drug ineffective among females and scleroderma among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Stelara. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Stelara?

Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.



On Jul, 14, 2026

52 people who take Abilify and Stelara together, and have interactions are studied.

Abilify and Stelara drug interactions.

What are the common drug interactions of Abilify and Stelara, by gender? *:

female:

  1. Drug ineffective
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Pancreatitis (inflammation of pancreas)
  4. Fatigue (feeling of tiredness)
  5. Erythema (redness of the skin)
  6. Infusion related reaction
  7. Anxiety
  8. Back pain
  9. Blood pressure increased
  10. Crying

male:

  1. Scleroderma (hard skin)
  2. Drug ineffective
  3. Accident
  4. Back injury
  5. Carpal tunnel decompression
  6. Confusional state
  7. Death
  8. Delusion (a false belief or opinion)
  9. Dizziness
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Abilify and Stelara, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Accident
  2. Back injury
  3. Nasal discomfort
  4. Nasal dryness (dry nose)
  5. Post procedural infection
  6. Viith nerve paralysis

30-39:

  1. Pain
  2. Acne (skin problems that cause pimples)

40-49:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Drug ineffective
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Anxiety
  5. Back pain
  6. Blood pressure increased
  7. Crying
  8. Fatigue (feeling of tiredness)
  9. Hallucination, tactile (sensation of physical contact with an object that isn't there)
  10. Hallucination, visual (seeing things that aren't there)

50-59:

  1. Pancreatitis (inflammation of pancreas)
  2. Erythema (redness of the skin)
  3. Infusion related reaction
  4. Hypopnoea (decrease in the breathing rate)
  5. Abnormal faeces (abnormal stool)
  6. Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)
  7. Drug ineffective
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Spinal stenosis (narrowing of spinal column)

60+:

  1. Arthralgia (joint pain)
  2. Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
  3. Joint swelling
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Mania (a state of abnormally elevated or irritable mood)
  6. Restlessness (not able to rest)
  7. Staphylococcus test positive
  8. Confusional state
  9. Culture positive
  10. Death

What are the existing conditions these people have? *

  1. Stress And Anxiety: 9 people, 17.31%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 9 people, 17.31%
  3. Thyroid Diseases: 6 people, 11.54%
  4. Bipolar Disorder (mood disorder): 6 people, 11.54%
  5. Post-Traumatic Pain: 5 people, 9.62%
  6. Post Concussion Syndrome: 5 people, 9.62%
  7. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 7.69%
  8. Diabetes: 3 people, 5.77%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Stelara?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Stelara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Stelara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Stelara and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and ustekinumab (the active ingredients of Abilify and Stelara, respectively), and Abilify and Stelara (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: